We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Food and drink labelling and packaging regulations - what you must show, warnings, health and organic labels and packaging standards.
To sell food and drink products, the label must be: clear and easy to read…
You must show the following information: the name of the food a ‘best…
If your food or drink product has 2 or more ingredients (including any…
You must show an appropriate warning on the label if your food contains…
Nutrition labelling You must follow nutrition labelling information rules…
If you’re a retailer, you can label products ‘organic’ as long as: at…
Batches of quetiapine oral suspension from Eaststone Limited are being recalled due to the active content being twice the amount it should be. Patients should not stop taking this medicine without consulting their healthcare professional.
Find out what a composite food product is, and the rules you need to follow to export or move these products from Great Britain to the EU and Northern Ireland.
A form of IP that extends the protection of patented active ingredients present in pharmaceutical or plant protection products.
How to register as a manufacturer, importer or distributor of active substances.
Common basic data set (CBDS) and assessment component files for use by software suppliers developing management information systems (MIS).
Viatris has received reports of brown discolouration and blockage in the needle of pre-filled syringes of Arixtra. This quality defect is related to oxidation of the syringe needle.
Eaststone Limited is initiating a recall of all batches of quetiapine oral suspension products due to a potential risk of overdose, which could have consequences for the safety of patients.
Baxter Healthcare Corporation have informed the MHRA that the Patient Information Leaflet (PIL) packed in specified batches does not contain up to date information relating to the duration of contraception required for females after stopping taking this medication.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).